Tranexamic Acid Infusion Dosing for Adults with Normal Renal Function
For bleeding trauma patients with normal renal function, administer tranexamic acid as a 1 g loading dose over 10 minutes, followed by a 1 g maintenance infusion over 8 hours (maximum daily dose: 2 g). This represents the most strongly evidence-based regimen for mortality reduction in hemorrhagic emergencies.
Loading Dose and Maintenance Infusion
The CRASH-2 trial regimen is the gold standard for trauma and major hemorrhage, supported by the highest quality evidence demonstrating mortality benefit 1:
- Loading dose: 1 g IV over 10 minutes
- Maintenance infusion: 1 g IV over 8 hours
- Maximum daily dose: 2 g total
- Critical timing: Must be administered within 3 hours of injury/bleeding onset 1, 2
This fixed-dose regimen supersedes older weight-based dosing recommendations and has been validated in over 20,000 patients, showing significant reduction in all-cause mortality (relative risk 0.91,95% CI 0.85-0.97) and death from bleeding (relative risk 0.85,95% CI 0.76-0.96) 1.
Alternative Weight-Based Dosing (Context-Specific)
For surgical settings where the CRASH-2 regimen may not apply, European trauma guidelines suggest 3:
- Loading dose: 10-15 mg/kg IV
- Maintenance infusion: 1-5 mg/kg/hour
- Duration: Continue until bleeding is controlled
However, this dosing range is less well-defined and based primarily on cardiac surgery data extrapolated to trauma. The Horrow regimen (10 mg/kg bolus + 1 mg/kg/hour) achieves therapeutic plasma levels of 10 μg/mL required for fibrinolysis inhibition 3.
Critical Timing Considerations
Timing is more important than the exact dose. The benefit of tranexamic acid decreases by 10% for every 15-minute delay in administration 2:
- Within 1 hour: Maximum benefit
- 1-3 hours: Decreasing benefit
- After 3 hours: No benefit and potentially harmful 1, 2
For this reason, WHO and updated guidelines strongly recommend initiating tranexamic acid as early as possible, ideally in the pre-hospital setting for trauma patients 2.
Infusion Rate and Safety
Infuse no faster than 1 mL/minute (100 mg/minute) to avoid hypotension 4. The 1 g dose given over 10 minutes in CRASH-2 translates to approximately 1.7 mL/minute, which is generally well-tolerated but monitor blood pressure during administration.
Maximum Daily Dose Limits
The maximum recommended daily dose is 2 g (1 g loading + 1 g maintenance over 8 hours) based on the CRASH-2 protocol 1.
For postpartum hemorrhage, WHO guidelines allow a second 1 g dose if bleeding continues after 30 minutes or restarts within 24 hours, but this is specific to obstetric hemorrhage 2.
Studies using boluses up to 5 g have been reported without adverse effects in cardiac surgery 3, but higher doses (>4 g) are associated with significantly increased thromboembolic risk (HR 5.33,95% CI 1.94-14.63) 5 and seizure risk 6.
Important Caveats
Do not use tranexamic acid:
- Beyond 3 hours after bleeding onset (no benefit, potential harm) 1, 2
- In patients with subarachnoid hemorrhage (risk of cerebral edema/infarction) 4
- In patients with active intravascular clotting 4
Renal dosing adjustment: The question specifies normal renal function, but be aware that tranexamic acid is renally excreted and requires dose reduction in renal impairment 3, 4. For serum creatinine 1.36-2.83 mg/dL, reduce to 10 mg/kg twice daily; for >5.66 mg/dL, reduce to 10 mg/kg every 48 hours 4.
Seizure risk: While the CRASH-2 regimen showed no increased seizure risk in trauma 1, higher doses used in cardiac surgery (particularly >100 mg/kg total dose) are associated with increased seizure incidence 6, 7. The 2 g total dose in CRASH-2 represents approximately 25-30 mg/kg for a 70-80 kg adult, well below the high-risk threshold.